Exhibit 23.2




               Consent of Ernst & Young LLP, Independent Auditors


We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) and related Prospectus of Ligand
Pharmaceuticals for the registration of shares of its common stock and to the
incorporation by reference therein of our report dated February 22, 2000, with
respect to the consolidated financial statements and schedules of Ligand
Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year
ended December 31, 1999, filed with the Securities and Exchange Commission.

                                                               ERNST & YOUNG LLP

San Diego, California
April 26, 2002